跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LUCRIN DEPOT leuprorelin acetate 45mg powder for suspension prefilled dual-chamber syringe injection - TGA Drug Approval Details
Approvals
/
TGA
/
LUCRIN DEPOT leuprorelin acetate 45mg powder for suspension prefilled dual-chamber syringe injection
Approved
STANDARD
LUCRIN DEPOT leuprorelin acetate 45mg powder for suspension prefilled dual-chamber syringe injection
AbbVie Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
643dd3b25154557d
Company
AbbVie Pty Ltd
Type
Standard
Approval Details
Approval Id
643dd3b25154557d
Product Name
LUCRIN DEPOT leuprorelin acetate 45mg powder for suspension prefilled dual-chamber syringe injection
Artg Id
222375
Artg Name
LUCRIN DEPOT leuprorelin acetate 45mg powder for suspension prefilled dual-chamber syringe injection
Sponsor
AbbVie Pty Ltd
Company Detail Path
/organization/abbvie-pty-ltd
Artg Date
2015-05-12
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/47044a1de38a3dd13364c28407808903.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/3766ff8e54dfddcfe5ce365786759c31.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
643dd3b25154557d
Type
Standard
Back to TGA Approvals